H. Fujioka et al. / Tetrahedron Letters 46 (2005) 2197–2199
2199
Table 4.
Rettori, M. C.; Renard, P. Bioorg. Med. Chem. 2001, 9,
585–592.
2. For examples, see: (a) Jones, R. C. F.; Nichols, J. R.
Tetrahedron Lett. 1990, 31, 1771–1774; (b) Jung, M. E.;
Huang, A. Org. Lett. 2000, 2, 2659–2661.
Ph
Ph
(1.05eq)
H2N
NH2
H
N
Ph
Ph
then NBS (1.05eq)
3. For examples, see: (a) Jones, R. C. F.; Turner, I.; Howard,
K. J. Tetrahedron Lett. 1993, 34, 6329–6332; (b) Langlois,
Y.; Dalko, P. I. J. Org. Chem. 1998, 63, 8107–8117.
4. For examples, see: (a) Morimoto, T.; Tachibana, K.;
Achiwa, K. Synlett 1997, 783–785; (b) Davinport, A. J.;
Davies, D. L.; Fawcett, J.; Russell, D. R. J. Chem. Soc.,
Perkin Trans. 1 2001, 1500; (c) Menges, F.; Neuburger,
M.; Pfaltz, A. Org. Lett. 2002, 4, 4713–4716.
5. For the examples, see: (a) Ferm, R. J.; Riebsomer, J. L.
Chem. Rev. 1954, 54, 593–613; (b) Botteghi, C.; Schionato,
A. J. Organomet. Chem. 1989, 370, 17–31; (c) Corbel, J.
C.; Uriac, P.; Huet, J.; Martin, C. A. E.; Advenier, C. Eur.
J. Med. Chem. 1995, 30, 3–13; (d) Pigini, M.; Bousquet, P.;
Carotti, A.; Dontenwill, M.; Giannella, M.; Moriconi, R.;
Piergentili, A.; Quaglia, W.; Tayebati, S. K.; Brasili, L.
Bioorg. Med. Chem. 1997, 5, 833–841; (e) Mitchell, J. M.;
Finney, N. S. Tetrahedron Lett. 2000, 41, 8431–8434.
6. For examples, see: (a) Neef, G.; Eder, U.; Sauer, G. J.
Org. Chem. 1981, 46, 2824–2826; (b) Rondu, F.; Bihan, G.
L.; Wang, X.; Lamouri, A.; Toubou, E.; Dive, G.;
Bellahsene, T.; Pfeiffer, B.; Renard, P.; Guardiola-Lemai-
tre, B.; Manechez, D.; Penicaud, L.; Ktorza, A.; Godfroid,
J.-J. J. Med. Chem. 1997, 40, 3793–3803; (c) Touzeau, F.;
Arrault, A.; Guillaumet, G.; Scalbert, E.; Pfeiffer, B.;
R
R CHO
CH2Cl2
0oC-rt.
N
Entry
R–CHO
Yield (%)
CHO
1
92
96
2
N
CHO
CHO
3
4
87
95
Ts
N
CHO
hydes and 1,2-diamines. This method works at low tem-
perature, 0 °C–rt, and many functional groups such as
halogens, esters, and nitriles can exist without any prob-
lem. Furthermore, since the aldehyde is a popular func-
tional group, the method here is considered useful in
organic synthesis.
´
Rettori, M.-C.; Renard, P.; Merour, J.-Y. J. Med. Chem.
2003, 46, 1962–1979.
7. For examples, see: (a) Peddibhotla, S.; Tepe, J. J. Synthesis
2003, 1433–1440; (b) Huh, D. H.; Ryu, H.; Kim, Y. G.
Tetrahedron 2004, 60, 9857–9862; (c) You, S.-L.; Kelly, J.
W. Org. Lett. 2004, 6, 1681–1683.
References and notes
8. Among the examined reaction solvents, toluene, CH2Cl2,
AcOEt, and THF, CH2Cl2 gave the best results (99% yield
of 2), whereas other three solvents afforded 2 in decreased
yields (toluene, 75% of 2; AcOEt, 73% of 2; THF, 76%
yield of 2).
9. Eluent for the compounds in entries 1, 3, 5–9 in Table 2:
AcOEt/Et3N system; eluent for the compounds in entries
2, 4, 10in Table 2 and entries 1, 2 in Table 3: CH2Cl2/
MeOH/Et3N system; eluent for the compounds in entries
3–5 in Table 3: CH2Cl2/MeOH/Et3N system; eluent for the
compounds in Table 4: hexane/AcOEt/Et3N system.
10. Transformation of C–N single bond to C–N double bond
from N-chloroamine, see: Scully, F. E., Jr.; Davis, R. C. J.
Org. Chem. 1978, 43, 1467–1468.
1. For examples, see: (a) Greenhill, J. V.; Lue, L. In Progress
in Medicinal Chemistry; Ellis, G. P., Luscombe, D. K.,
Eds.; Elsevier: New York, 1993; Vol. 3; (b) Grimmett, M.
R. In Comprehensive Heterocyclic Chemistry; Katrizky, A.
R., Rees, C. W., Sciven, E. F. V., Eds.; Pergamon: Oxford,
1996; Vol. 3, pp 77–220; (c) Prisinzano, T.; Law, H.;
Dukat, M.; Slassi, A.; MaClean, N.; Demchyshyn, L.;
Glennon, R. A. Bioorg. Med. Chem. 2001, 9, 613–619; (d)
Gilman, A. G.; Goodman, L. S. The Pharmacological
Basic of Therapeutics, 10th ed.; Macmillan & Co: New
York, 2001; (e) Anasatassiadou, M.; Danoun, S.; Crane,
L.; Baziard-Mouysset, G.; Payard, M.; Caignard, D. H.;